Shoulder Innovations

Shoulder Innovations Capital Expenditures

The Capital Expenditures (CapEx) of Shoulder Innovations (SI) as of Oct 15, 2026 is -7.41 M USD. In the previous year, Capital Expenditures (CapEx) was -4.02 M USD — a change of 84.51% (lower).

Capital Expenditures

-7.41 MUSD

YoY

84.51%

Last updated:

Capital Expenditures (CapEx) of Shoulder Innovations is 2025 -7.41 M USD. Capital Expenditures (CapEx) of Shoulder Innovations was 2024 -4.02 M USD. It decreases by 84.51% lower compared to the previous year.

The Shoulder Innovations Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-2.66 M USD
Jan 1, 2019
-1.21 M USD
Jan 1, 2020
-920,000.00 USD
Jan 1, 2021
-1.92 M USD
Jan 1, 2022
-2.35 M USD
Jan 1, 2023
-2.75 M USD
Jan 1, 2024
-4.02 M USD
Jan 1, 2025
-7.41 M USD
The Shoulder Innovations Capital Expenditures history
YEARCapital ExpendituresYoY
-7.41 MUSD+84.51%
-4.02 MUSD+46.11%
-2.75 MUSD+16.74%
-2.35 MUSD+22.60%
-1.92 MUSD+108.70%
-920,000.00USD-23.97%
-1.21 MUSD-54.51%
-2.66 MUSD+137.50%
-1.12 MUSD+89.83%
-590,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shoulder Innovations Stock analysis

What does Shoulder Innovations do? Shoulder Innovations Inc, with ticker SI and ISIN US82537J1088, is a US-based health care company headquartered in Grand Rapids. The company operates in the Health Care sector, specifically within the Health Care Equipment & Supplies industry. Shoulder Innovations Inc has 72 employees and is scheduled to go public on July 31, 2025. The company focuses on developing advanced implant systems for shoulder arthroplasty, aiming to transform the shoulder surgical care market. Its product offerings include aTSA and rTSA systems, designed to address patient and surgeon needs through customizable components for anatomic or reverse configurations. The company's ecosystem encompasses enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration. Shoulder Innovations Inc emphasizes improving preoperative planning, implant design, and procedural efficiency to benefit stakeholders across the care chain. The company's website is shoulderinnovations.com, and it is positioned as a commercial-stage medical technology firm. The company's operational details, including its focus on shoulder surgical care and its product systems, are central to its business model. The company's IPO date is set for July 31, 2025, marking a significant milestone in its growth trajectory. The company's approach integrates advanced implant systems with supporting technologies to enhance surgical outcomes and streamline care processes. Shoulder Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shoulder Innovations stock

Capital Expenditures (CapEx) of Shoulder Innovations is -7.41 M USD in 2025.

Capital Expenditures (CapEx) of Shoulder Innovations changed from -4.02 M USD to -7.41 M USD, representing a 84.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Shoulder Innovations since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Shoulder Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Shoulder Innovations

All Key Metrics — Shoulder Innovations